Injective rockets, recoils, and rallies again: INJ bulls eye $6 after wild swings
The gist
Injective’s INJ token is back in the spotlight, rocketing past resistance after wild swings and strategic moves that have bulls eyeing the $6 mark—and beyond.
What to know
- INJ surged nearly 35% in mid-May after aggressive buybacks and the rollout of native USDC integration, boosting both liquidity and investor hype.
- A sharp 19% drop in early June highlighted the token’s volatility as a broad crypto sell-off slammed large-cap altcoins.
- By mid-June, INJ rebounded with a 12.89% rally in 24 hours, smashing through $5.76 and challenging the crucial $6.06 resistance level.
Buybacks Ignite Bull Frenzy
Aggressive INJ buybacks and USDC integration slashed supply and expanded utility, turbocharging bullish sentiment and drawing a surge of new investors.
Injective's initial rally, which began steadily in early April, gained significant momentum by mid-May, fueled primarily by strategic INJ token buybacks and the expansion of USDC integration. This combination sparked heightened investor interest, propelling the price to surge over 12% within 24 hours and nearly 35% over the preceding week, signaling robust bullish sentiment in the market. The buybacks not only reduced circulating supply but also underscored the team's confidence in INJ's long-term value, amplifying market enthusiasm.
The launch of native USDC integration on May 29 marked a pivotal moment for Injective, driving the token price to a breakout level of $6.206 and pushing it toward $6.50. By enabling access to Circle's regulated stablecoin liquidity, this integration opened new avenues for trading tokenized stocks and pre-IPO assets on the Injective network, significantly enhancing its utility and appeal. This strategic catalyst not only reinforced the earlier bullish momentum but also positioned Injective as a more versatile and liquid platform, attracting a broader investor base.
Market Rout Tests INJ Nerves
A 19% plunge in early June exposed Injective’s vulnerability to macro crypto shocks, raising questions about its resilience amid shifting risk appetites.
In early June 2026, Injective (INJ) faced a pronounced market challenge as its price plummeted by 19%, positioning it among the most severely impacted large-cap altcoins during a widespread sell-off. This sharp decline not only underscored intense selling pressure but also mirrored a broader contraction in risk appetite across the cryptocurrency landscape, amplifying concerns about INJ's ability to rebound swiftly from the downturn.
Breakouts Fuel Renewed Momentum
Successive rallies above key resistance levels signaled a decisive shift in market conviction, with traders eyeing Fibonacci retracements for confirmation of sustained bullish strength.
By late May 2026, Injective demonstrated a robust recovery, surging 14.4% to break through the $6 resistance level and reach a six-month high of $6.3, a milestone not seen since November 2025. This breakout marked a clear resurgence of bullish momentum, signaling renewed investor confidence in INJ's upward trajectory.
Mid-June saw Injective continue its upward climb, breaking above the $5.76 level with a notable 12.89% surge within 24 hours, fueled by increased trading volume and momentum. This price action reflected a decisive shift in market sentiment, as INJ moved out of a week-long consolidation phase and challenged the critical $6.06 resistance, a key Fibonacci retracement level that traders are closely watching for confirmation of sustained bullish strength.